Trials / Withdrawn
WithdrawnNCT00699530
Substrate Metabolism and Insulin Sensitivity in Patients With Hyperprolactinemia Before and After Treatment
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the effects of chronic elevated levels of Prolactin on metabolism and insulin sensitivity by studying patients with hyperprolactinemia before and after treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cabergoline | Cabergoline 0,25 - 1,0 mg once a week, controlled by our outpatient clinic. The drug regimen is not influenced by participating in this study. |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2016-11-01
- Completion
- 2016-11-01
- First posted
- 2008-06-18
- Last updated
- 2017-12-22
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00699530. Inclusion in this directory is not an endorsement.